IEEE Trans Neural Syst Rehabil Eng. 2020 Nov;28(11):2459-2467. doi: 10.1109/TNSRE.2020.3027393. Epub 2020 Nov 6.
Delivery of neurotrophins to the spinal injury site via cellular transplants or viral vectors administration has been shown to promote recovery of locomotion in the absence of locomotor training in adult spinalized animals. These delivery methods involved risks of secondary injury to the cord and do not allow for precise and controlled dosing making them unsuitable for clinical applications. The present study was aimed at evaluating the locomotor recovery efficacy and safety of the neurotrophin BDNF delivered intrathecally to the lumbar locomotor centers using an implantable and programmable infusion mini-pump. Results showed that BDNF treated spinal cats recovered weight-bearing plantar stepping at all velocities tested (0.3-0.8 m/s). Spinal cats treated with saline did not recover stepping ability, especially at higher velocities, and dragged their hind paws on the treadmill. Histological evaluation showed minimal catheter associated trauma and tissue inflammation, underlining that intrathecal delivery by an implantable/programmable pump is a safe and effective method for delivery of a controlled BDNF dosage; it poses minimal risks to the cord and is clinically translational.
通过细胞移植或病毒载体给药将神经营养因子递送到脊髓损伤部位已被证明可促进成年脊髓损伤动物在没有运动训练的情况下运动功能的恢复。这些传递方法涉及对脊髓的二次损伤的风险,并且不允许进行精确和控制的剂量给药,因此不适合临床应用。本研究旨在评估使用可植入和可编程输注微型泵鞘内递送至腰运动中枢的神经营养因子 BDNF 的运动恢复效果和安全性。结果表明,BDNF 处理的脊髓猫在所有测试速度(0.3-0.8 m/s)下均恢复了负重踏地行走能力。用生理盐水处理的脊髓猫未恢复行走能力,尤其是在较高速度下,并且在跑步机上拖着后脚。组织学评估显示导管相关的创伤和组织炎症最小,这表明通过可植入/可编程泵鞘内递药是一种安全有效的方法,可递送电刺激治疗所需的受控 BDNF 剂量;它对脊髓的风险最小,具有临床转化前景。